Mode
Text Size
Log in / Sign up
Phase 2 N=140 Randomized Triple-blind Treatment

Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in Sepsis.

Sepsis, Severe · Septic Shock

Enrolled (actual)
140
Serious AEs
0.0%
Results posted
Sep 2021
Primary outcome: Primary: Time to Vasopressor Independence (Hours) — 27; 53 hours — p=<0.001

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Ascorbic Acid (Drug); Thiamine (Drug); Hydrocortisone (Drug); Sodium Chloride 0.9% (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Community Medical Center, Toms River, NJ
Primary completion
Jun 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Vasopressor Independence (Hours)
27; 53 <0.001 sig
PRIMARY
Change in Sequential Organ Failure Assessment (SOFA) Score
2.9; 1.93
SECONDARY
Procalcitonin (PCT) Clearance
63; 58
SECONDARY
ICU Mortality
6; 10
SECONDARY
ICU Length of Stay
4.76; 4.66
SECONDARY
Ventilator Free Days
22; 22.4
SECONDARY
Hospital Length of Stay
11.5; 11
SECONDARY
Hospital Mortality
11; 13

Summary

This study has been created to compare the addition of intravenous (IV) vitamin C, thiamine, and hydrocortisone to the usual standard of care of sepsis and septic shock. Sepsis is a possibly life-threatening condition in which a patient may have organ dysfunction due to an infection. Septic shock is defined as low blood pressure and organ dysfunction that do not improve after administering IV fluids. Standard of care for sepsis and septic shock include early administration of IV antibiotics, IV fluids, and vasopressors if need be to provide oxygen to vital organs. A large amount of experimental data has shown that vitamin C and corticosteroids decrease the release of inflammatory substances which may lead to organ failure seen in sepsis. Vitamin C and corticosteroids also improve blood flow to vital organs and increase the body's ability to respond well to vasopressor medications used in septic shock. Low blood levels of both thiamine and vitamin C are common in sepsis. The study will be placebo controlled, meaning one group will receive vitamin C, thiamine, and hydrocortisone, and the other will receive an inactive substance ("placebo"). The goal of the study is to compare the effects of receiving vitamin C, thiamine, and hydrocortisone (along with the standard sepsis care) versus placebo and standard sepsis care.

Eligibility Criteria

Inclusion Criteria

i. Diagnosis of sepsis or septic shock within 12 hours of admission to the ICU ii. Informed consent as dictated by IRB and local practice. iii. Compliance with the 3 hour sepsis bundle

  • 30ml/kg of intravenous crystalloid fluid (e.g.: sodium chloride 0.9%) for lactic acid >4 and/or systolic blood pressure 24 hours after admission
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03422159). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search